Clinical Trials Directory

Trials / Completed

CompletedNCT01002144

C-Reactive Protein as a Predictor for Airway Hyper-Responsiveness

C-Reactive Protein as a Predictor for Airway Hyper-responsiveness

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Background: Increased serum high sensitivity C-reactive protein (hs-CRP) has been associated with airway inflammation in asthma and may serve as a surrogate marker for the presence of airway hyper-responsiveness (AHR) in this set-up. This study was designed to evaluate the predictive value of hs-CRP for AHR assessed by metacholine challenge test (MCT), in adults with suspected Asthma.

Conditions

Interventions

TypeNameDescription
OTHERblood sampling

Timeline

Start date
2007-03-01
Primary completion
2009-03-01
Completion
2009-05-01
First posted
2009-10-27
Last updated
2009-10-27

Source: ClinicalTrials.gov record NCT01002144. Inclusion in this directory is not an endorsement.

C-Reactive Protein as a Predictor for Airway Hyper-Responsiveness (NCT01002144) · Clinical Trials Directory